These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2952267)

  • 1. D-1 and D-2 receptor manipulation in Cebus monkeys: implication for extrapyramidal syndromes in humans.
    Gerlach J; Casey D; Kistrup K
    Clin Neuropharmacol; 1986; 9 Suppl 4():131-3. PubMed ID: 2952267
    [No Abstract]   [Full Text] [Related]  

  • 2. D-1/D-2 dopamine receptor interactions in the regulation of extrapyramidal motor function: studies in animal models and parkinsonian patients.
    Barone P; Braun AR; Chase TN
    Clin Neuropharmacol; 1986; 9 Suppl 4():128-30. PubMed ID: 2952266
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of selective D1 and D2 dopamine receptor antagonists and agonists in Cebus monkeys: implications for acute and tardive dyskinesias. A preliminary report.
    Gerlach J; Kistrup K; Korsgaard S
    Psychopharmacol Ser; 1987; 3():236-42. PubMed ID: 3547396
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective D1 and D2 receptor manipulation in Cebus monkeys: relevance for dystonia and dyskinesia in humans.
    Kistrup K; Gerlach J
    Pharmacol Toxicol; 1987 Sep; 61(3):157-61. PubMed ID: 2891133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulation of neural transmission in the mouse vas deferens by 2 subtypes of dopaminergic receptors].
    Mitolo-Chieppa D; Carratù MR; De Serio A; Ferrari E; Conte-Camerino D; Damiani M
    Boll Soc Ital Biol Sper; 1988 Aug; 64(8):763-8. PubMed ID: 2850821
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects.
    Peacock L; Hansen L; Mørkeberg F; Gerlach J
    Neuropsychopharmacology; 1999 Jan; 20(1):35-43. PubMed ID: 9885783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-1 dopamine receptors and arousal.
    Ongini E
    Adv Exp Med Biol; 1988; 235():169-78. PubMed ID: 2976250
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.
    Lublin H; Gerlach J; Peacock L
    Psychopharmacology (Berl); 1993; 112(2-3):389-97. PubMed ID: 7871047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
    Lublin H; Gerlach J; Mørkeberg F
    Psychopharmacology (Berl); 1994 Apr; 114(3):495-504. PubMed ID: 7855208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural differentiation between effects elicited at dopamine D-1 and D-2 receptors in rats.
    Arnt J; Hyttel J
    Clin Neuropharmacol; 1986; 9 Suppl 4():17-9. PubMed ID: 2952268
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors.
    Coffin VL; Latranyi MB; Chipkin RE
    J Pharmacol Exp Ther; 1989 Jun; 249(3):769-74. PubMed ID: 2567351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1988; 2(4):416-23. PubMed ID: 2973142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors.
    Nowak G; Arnt J; Hyttel J
    Eur J Pharmacol; 1988 Aug; 153(2-3):309-11. PubMed ID: 3053212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors.
    Braun AR; Barone P; Chase TN
    Adv Exp Med Biol; 1986; 204():151-66. PubMed ID: 2947426
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of the intrastriatal administration of selective dopaminergic agonists on Fos expression in the rat brain.
    Blandini F; Fancellu R; Orzi F; Conti G; Greco R; Tassorelli C; Nappi G
    Neurol Sci; 2002 Sep; 23 Suppl 2():S57-8. PubMed ID: 12548342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adrenalectomy on responses mediated by dopamine D-1 and D-2 receptors.
    Faunt JE; Crocker AD
    Eur J Pharmacol; 1989 Mar; 162(2):237-44. PubMed ID: 2566498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.